Newsroom

Displaying 1–10 of 146

September 23, 2026

Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026

September 21, 2026

Seer Announces CFO Transition

September 16, 2026

Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale

August 11, 2026

Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

August 3, 2026

Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference 

August 3, 2026

Seer to Report Second Quarter 2026 Financial Results on August 11, 2026

July 30, 2026

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

July 28, 2026

Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting

July 20, 2026

Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY

July 20, 2026

Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence